RELATIONSHIP BETWEEN APOLIPOPROTEIN-E AND LOW-DENSITY-LIPOPROTEIN PARTICLE-SIZE

被引:25
作者
ZHAO, SP
VERHOEVEN, MH
VINK, J
HOLLAAR, L
VANDERLAARSE, A
DEKNIJFF, P
VANTHOOFT, FM
机构
[1] LEIDEN UNIV HOSP,DEPT CARDIOL,2333 AA LEIDEN,NETHERLANDS
[2] TNO,IVVO,GAUBIUS LAB,2313 AD LEIDEN,NETHERLANDS
[3] KAROLINSKA HOSP,KING GUSTAVE V RES INST,S-10401 STOCKHOLM 60,SWEDEN
[4] HUNAN MED UNIV,2ND AFFILIATED HOSP,CARDIOVASC RES LAB,CHANGSHA 410011,PEOPLES R CHINA
关键词
LOW DENSITY LIPOPROTEIN PARTICLE SIZE; APOLIPOPROTEIN-A-I; APOLIPOPROTEIN-A-II; APOLIPOPROTEIN-A-IV; APOLIPOPROTEIN-B AND APOLIPOPROTEIN-E; LIPID; LIPOPROTEIN;
D O I
10.1016/0021-9150(93)90156-O
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationships between the particle size of low density lipoproteins (LDL) and various lipid parameters, including apolipoprotein (apo) E concentration and apo E phenotype, were analyzed in plasma samples obtained from 196 apparently healthy 35-year-old males. The LDL particle size was determined by gradient gel electrophoresis. Using stepwise multiple regression analysis it was found that LDL particle size correlated negatively to the plasma concentrations of triglyceride (r = -0.497, P < 0.001), apo E (r = -0.415, P < 0.001), apo B (r = -0.395, P < 0.001) and cholesterol (r = -0.235, P < 0.001) and correlated positively to the plasma concentrations of apo A-I (r = 0.297, P < 0.001) and apo A-II (r = 0. 145, P < 0.05). However, the LDL particle size did not differ significantly among the different apo E phenotypes. Indeed, when entered as a variable in the multiple regression analysis, the apo E phenotype was not correlated to the LDL particle size. It is concluded that the LDL particle size is related to the plasma concentrations of triglyceride, apo E, apo B, apo A-I, apo A-II and cholesterol and is not affected by the apo E phenotype in healthy 35-year-old males.
引用
收藏
页码:147 / 154
页数:8
相关论文
共 45 条
[1]  
AUSTIN MA, 1988, AM J HUM GENET, V43, P838
[2]   INHERITANCE OF LOW-DENSITY-LIPOPROTEIN SUBCLASS PATTERNS IN FAMILIAL COMBINED HYPERLIPIDEMIA [J].
AUSTIN, MA ;
BRUNZELL, JD ;
FITCH, WL ;
KRAUSS, RM .
ARTERIOSCLEROSIS, 1990, 10 (04) :520-530
[3]  
AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
[4]   ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK [J].
AUSTIN, MA ;
KING, MC ;
VRANIZAN, KM ;
KRAUSS, RM .
CIRCULATION, 1990, 82 (02) :495-506
[5]  
AUSTIN MA, 1986, LANCET, V2, P592
[6]   KOCHS POSTULATES FOR CHOLESTEROL [J].
BROWN, MS ;
GOLDSTEIN, JL .
CELL, 1992, 71 (02) :187-188
[7]  
BURY J, 1985, CLIN CHEM, V31, P247
[8]  
BURY J, 1986, CLIN CHEM, V32, P265
[9]   LOW-DENSITY-LIPOPROTEIN PARTICLE-SIZE AND CORONARY-ARTERY DISEASE [J].
CAMPOS, H ;
GENEST, JJ ;
BLIJLEVENS, E ;
MCNAMARA, JR ;
JENNER, JL ;
ORDOVAS, JM ;
WILSON, PWF ;
SCHAEFER, EJ .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (02) :187-195
[10]   DIFFERENCES IN APOLIPOPROTEINS AND LOW-DENSITY-LIPOPROTEIN SUBFRACTIONS IN POSTMENOPAUSAL WOMEN ON AND OFF ESTROGEN THERAPY - RESULTS FROM THE FRAMINGHAM OFFSPRING STUDY [J].
CAMPOS, H ;
WILSON, PWF ;
JIMENEZ, D ;
MCNAMARA, JR ;
ORDOVAS, J ;
SCHAEFER, EJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (10) :1033-1038